ArticleIndian journal of community medicine : official publication of Indian Association of Preventive & Social Medicine2026
Tobacco Industry's Corporate Diversification in the Evolving Landscape of Tobacco Control Laws in India - A Comparative Time-Series Analysis.
Article in Indian journal of community medicine : official publication of Indian Association of Preventive & Social Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: India has established a strong policy framework to curb tobacco use-a significant risk factor for noncommunicable diseases (NCDs)-by enforcing Cigarettes and Other Tobacco Products Act (COTPA) 2003 and ratifying WHO-Framework Convention on Tobacco Control (WHO-FCTC) 2003. Within this regulatory context, India's tobacco companies have diversified business activities and adopted brand extension and other promotional strategies. This exploratory study examines these diversification and surrogate marketing practices and their relevance to tobacco control policy implementation and NCD prevention in India. Methodology: A historical review and secondary data analysis were conducted using company reports, academic literature, and industry sources. Six tobacco companies-ITC Limited, Godfrey Phillips India Ltd. (GPI), DS Group, Pataka, Miraj, and Mangalore Ganesh Beedi Works-were analyzed for diversification timelines, brand strategies, and regulatory responses. Qualitative analyses and time-series mapping were undertaken. Results: ITC Limited emphasized brand stretching using its Conclusions: Brand extension and surrogate marketing have sustained tobacco brand visibility within the current regulatory framework. Enforcing COTPA and WHO-FCTC Article 13 with more transparent oversight of corporate diversification may effectively restrict tobacco advertising, promotion, and sponsorship and strengthen NCD prevention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.